Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fasoracetam monohydrate is a small synthetic molecule and a metabotropic glutamate receptor activator, which has previously undergone extensive Phase I-III clinical trials in humans for vascular dementia.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | Fasoracetam monohydrate is a small synthetic molecule and a metabotropic glutamate receptor activator, which has previously undergone extensive Phase I-III clinical trials in humans for vascular dementia. |
Molecular Weight | 275.31 |
Formula | C11H21N3O5 |
CAS No. | 2055646-53-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fasoracetam monohydrate 2055646-53-0 NOV-140201 Fasoracetam NOV140201 JPI-547 hydrochloride JPI 547 NOV 140201 JPI547 JPI-547 HCl Fasoracetam Monohydrate inhibitor inhibit